NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
Frequently asked questions
What sector does NovAccess Global Inc (XSNX) operate in?
NovAccess Global Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is NovAccess Global Inc (XSNX) current stock price?
As of the latest data, NovAccess Global Inc stock price is $0.00, with a previous close of $0.00.
What is NovAccess Global Inc (XSNX) current market capitalization?
NovAccess Global Inc market cap is approximately 6.17 thousand.
What is NovAccess Global Inc (XSNX) Earnings Per Share (EPS)?
The trailing EPS is -$0.06.
Does NovAccess Global Inc (XSNX) pay dividends?
No. NovAccess Global Inc does not pay a dividend.
What is NovAccess Global Inc (XSNX) beta (volatility) score?
NovAccess Global Inc has a beta of 98.784, indicating very high volatility compared to the market.